Second, the tool itself should be refined and recalibrated by adding age, nutritional/functional markers (e.g., BMI, serum albumin, brief frailty screens) and selected comorbidities to improve discrimination for clinically meaningful infection endpoints, beyond VA-focused items alone. Here, ALB is linked to infection.